Ethereum News Today: Investors Shift to XRP, Ethereum as Solana's Momentum Wanes

Solana (SOL) has lost some of its luster, trading near $164 as of Tuesday amid waning bullish momentum in its derivatives market. Open interest-the total value of outstanding futures contracts-has plummeted to $7.72 billion, down from $14.83 billion in early October, signaling a retreat by retail investors. Technical indicators, including a falling wedge pattern on the SOL/USDT daily chart, suggest a potential 22% rebound to $200 if the price breaks above the upper trendline.

However, the Relative Strength Index at 40 and sub-200-day EMA levels underscore bearish sentiment.

Meanwhile, XRP is emerging as a formidable contender. According to Canary Capital Group, XRP's ETF, launched in late October, has already drawn $58 million in trading volume, outperforming recent Solana-focused ETFs. The XRP network's familiarity with traditional finance institutions gives it an edge over Solana, which is more entrenched in crypto-native ecosystems. This trend aligns with broader market shifts, as investors seek assets with clearer regulatory pathways and established use cases.

Ethereum (ETH) treasuries are also gaining traction as a strategic play. Companies like ETHZilla and BTCS Inc. are leveraging Ethereum's staking and DeFi ecosystems to generate yield. ETHZilla's Q3 2025 financials highlight a 70% deployment of its 102,273 ETH holdings into staking protocols, while BTCS boosted its Ethereum holdings by 124% quarter-over-quarter through its DeFi/TradFi Accretion Flywheel strategy. These initiatives reflect growing confidence in Ethereum's ability to deliver both capital appreciation and passive income.

Blockchain infrastructure firms are further amplifying Ethereum's appeal. Figure Technology Solutions, for example, is positioning itself as a $100 billion market cap player by tokenizing assets and expanding blockchain-native equity listings. Similarly, GameSquare's Q3 results showcased a three-pronged Web3 strategy, including Ethereum-based treasuries and yield-generating digital assets. Such moves highlight how traditional finance is increasingly integrating crypto-native tools to diversify revenue streams.

However, the crypto landscape remains fraught with risks. A class-action lawsuit against biotech firm MoonLake Immunotherapeutics (MLTX) serves as a cautionary tale for investors. The case alleges securities fraud tied to misleading claims about the company's drug candidate, SLK, which shares molecular targets with BIMZELX. While unrelated to crypto, the lawsuit underscores the importance of due diligence in speculative markets, where hype can obscure fundamentals.

For those who missed Solana's early gains, XRP and Ethereum-based treasuries offer compelling alternatives. XRP's ETF success and Ethereum's yield-generating capabilities align with broader institutional adoption trends. As the market digests these developments, investors must balance optimism with vigilance, ensuring their portfolios are diversified across both proven and emerging assets.